Cost-effectiveness of the implementation of [68Ga]Ga-PSMA-11 PET/CT at initial prostate cancer staging

Cost-effectiveness of the implementation of [68Ga]Ga-PSMA-11 PET/CT at initial prostate cancer staging

Abstract Background Despite its high specificity, PSMA PET/CT has a moderate to low sensitivity of 40–50% for pelvic lymph node detection, implicating that a negative PSMA PET/CT cannot rule out lymph node metastases. This study investigates a strategy of implementing PSMA PET/CT for initial prostat...

Full description

Bibliographic Details
Main Authors: Esmée C. A. van der Sar, Willem R. Keusters, Ludwike W. M. van Kalmthout, Arthur J. A. T. Braat, Bart de Keizer, Geert W. J. Frederix, Anko Kooistra, Jules Lavalaye, Marnix G. E. H. Lam, Harm H. E. van Melick
Format: Article
Language:English
Published: SpringerOpen 2022-08-01
Series:Insights into Imaging
Subjects:
Prostate cancer
PSMA PET/CT
Cost-effectiveness
Radioligand
Gallium
Online Access:https://doi.org/10.1186/s13244-022-01265-w

Internet

https://doi.org/10.1186/s13244-022-01265-w

Similar Items